↓ Skip to main content

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

Overview of attention for article published in BMC Infectious Diseases, November 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy
1 policy source
twitter
1 tweeter

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
37 Mendeley
Title
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
Published in
BMC Infectious Diseases, November 2012
DOI 10.1186/1471-2334-12-297
Pubmed ID
Authors

Peter Matthews, Marc Alpert, Galia Rahav, Denise Rill, Edward Zito, David Gardiner, Ron Pedersen, Timothy Babinchak, Paul C McGovern

Abstract

Complicated skin and skin structure infections (cSSSIs) frequently result in hospitalization with significant morbidity and mortality.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Ethiopia 1 3%
Switzerland 1 3%
Greece 1 3%
Unknown 33 89%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 6 16%
Researcher 6 16%
Student > Ph. D. Student 5 14%
Professor 4 11%
Student > Postgraduate 3 8%
Other 13 35%
Readers by discipline Count As %
Medicine and Dentistry 24 65%
Unspecified 6 16%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Biochemistry, Genetics and Molecular Biology 1 3%
Agricultural and Biological Sciences 1 3%
Other 3 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2019.
All research outputs
#3,975,382
of 13,696,978 outputs
Outputs from BMC Infectious Diseases
#1,326
of 5,097 outputs
Outputs of similar age
#40,338
of 145,938 outputs
Outputs of similar age from BMC Infectious Diseases
#69
of 395 outputs
Altmetric has tracked 13,696,978 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 5,097 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 145,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 395 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.